Pancreatic ductal adenocarcinoma (PDAC) is known for its aggressive biology and lethality. Superior to conventional biomedical research models, the focus of this study is on the development and use of well-established patient-derived organoids (PDO)- and xenografts (PDX), mimicking the tumor as it is present in a human body. The models are extensively analysed using advanced spatial-omics analysis to investigate the ability to recapitulate two main molecular subtypes of PDAC.
Originele taal-2English
StatusPublished - 10 jun 2021
EvenementEuropean Pancreatic Club - Verona - online event
Duur: 9 jun 202111 jun 2021


ConferenceEuropean Pancreatic Club


Duik in de onderzoeksthema's van 'Setting up a PDXO platform of pancreatic cancer with spatial-omics characterization'. Samen vormen ze een unieke vingerafdruk.

Citeer dit